Anti-D immunoglobulin

Drug Name (Brand)	Anti-D immunoglobulin *(Various)*
Indication	Routine anti-D prophylaxis (RAADP) – as per NICE TA 156
Traffic Light Classification	Red
NICE TA (plus link)	Overview \| Routine antenatal anti-D prophylaxis for women who are rhesus D negative \| Guidance \| NICE
Further Information: NICE recommendations, summary of meeting discussions, links to additional supporting docs etc. August 2008: NICE Technology Appraisal Guidance No. 156 states that routine antenatal anti-D prophylaxis (RAADP) is recommended as a treatment option for all pregnant women who are rhesus D (RhD) negative and who are not known to be sensitised to the RhD antigen. Preparations with the lowest associated acquisition cost available should be used.
Date of TAG recommendation / ratification		4/1/2000	Review Date